Nature Reviews Clinical Oncology
Vol. 23, Issue 2
Issue 2
2026
9
Articles
Articles in this Issue
The global epidemiology of acute myeloid leukaemia
Firas El Chaer, Jan P. Bewersdorf, Maximilian Stahl et al.
Feb 01, 2026
pp. 107-120
10.1038/s41571-025-01099-7
The development of CAR T cells for patients with CNS malignancies
Zev A. Binder, Stephen J. Bagley, Jessica B. Foster et al.
Feb 01, 2026
pp. 137-150
10.1038/s41571-025-01102-1
Towards biomarker-driven therapies for urothelial carcinoma
Sara Coca Membribes, Bernadett Szabados, Thomas Powles
Feb 01, 2026
pp. 92-106
10.1038/s41571-025-01095-x
Personalized intensification of treatment for hormone-sensitive prostate cancer
Michael A. Cilento, Lisa M. Butler, Louise Emmett et al.
Feb 01, 2026
pp. 121-136
10.1038/s41571-025-01100-3
AI and human expertise in cancer care — striving for synergy
Milit S. Patel, Edward Christopher Dee, Nancy Y. Lee
Feb 01, 2026
pp. 87-88
10.1038/s41571-025-01108-9
Could a COVID-19 vaccine improve the effectiveness of cancer immunotherapy?
Sacha Gnjatic
Feb 01, 2026
pp. 90-91
10.1038/s41571-025-01105-y
T-DXd plus pertuzumab effective as first-line therapy
Peter Sidaway
Feb 01, 2026
pp. 89-89
10.1038/s41571-025-01106-x
Sentinel lymph node biopsy improves surgical management of cervical cancer
Diana Romero
Feb 01, 2026
pp. 89-89
10.1038/s41571-025-01107-w
T-DXd shows promise in neoadjuvant therapy for HER2+ breast cancer
David Killock
Feb 01, 2026
pp. 89-89
10.1038/s41571-025-01103-0
All Issues
Journal Info
Publisher
Springer Science and Business Media LLC
ISSN
1759-4774
E-ISSN
1759-4782
Subject
Medicine
Language
English